|
Volumn 31, Issue 13, 2013, Pages 1619-1620
|
Radiotherapy for hepatocellular carcinoma with tumor vascular thrombus: Ready for prime time?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SORAFENIB;
CANCER CONTROL;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SIZE;
CANCER SURGERY;
CANCER SURVIVAL;
CHEMOEMBOLIZATION;
COMPUTER ASSISTED TOMOGRAPHY;
EDITORIAL;
GOLD STANDARD;
HEALTH CARE QUALITY;
HIGH RISK PATIENT;
HUMAN;
INTENSITY MODULATED RADIATION THERAPY;
LIVER CELL CARCINOMA;
MULTIMODALITY CANCER THERAPY;
OVERALL SURVIVAL;
PARTIAL HEPATECTOMY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION ONCOLOGIST;
STEREOTACTIC BODY RADIATION THERAPY;
TREATMENT PLANNING;
TUMOR INVASION;
TUMOR THROMBUS;
UNSPECIFIED SIDE EFFECT;
FEMALE;
LIVER TUMOR;
MALE;
NOTE;
CARCINOMA, HEPATOCELLULAR;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
|
EID: 84884558399
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.48.2703 Document Type: Editorial |
Times cited : (8)
|
References (8)
|